Pakistan joins 52 countries on Covid-19 research, development

Published August 27, 2021
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. —  AFP/File
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. — AFP/File

ISLAMABAD: Pakistan has enrolled to participate in the ‘Solidarity PLUS’ clinical trial led by the World Health Organisation (WHO) that will evaluate three potential drugs — artesunate, imatinib and infliximab — for the treatment of Covid-19 infections aiming to protect people from severe hospitalisation and death because of the pandemic.

WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study, making up the largest global collaboration on Covid-19 research and development.

The three potential drugs were selected by a panel of experts who assess all available evidence on relevant therapeutics. The drugs have proven effectiveness in treating other life-threatening diseases. Artesunate is used for severe malaria, imatinib for specific cancers, and infliximab for diseases of the immune system, such as Crohn’s disease and rheumatoid arthritis.

“Covid-19 has been the most disruptive public health challenge in the past century. In less than two years, the pandemic has claimed over 4.4 million lives across the world, overwhelmed health systems, and disrupted economies and societies.

“It is critical that we find effective treatments to prevent severe hospitalisation and death caused by Covid-19. We appreciate the efforts of countries in the region in collaborating on vital global studies for the treatment of Covid-19, in the spirit of solidarity,” said Dr Ahmed Al-Mandhari, WHO Regi­onal Director for the Eastern Mediterranean.

Published in Dawn, August 27th, 2021

Opinion

Editorial

Gruesome murders
Updated 12 Jul, 2025

Gruesome murders

Long-term security can only be achieved when there is equitable development across Balochistan.
Solar policy
12 Jul, 2025

Solar policy

SOLAR net metering reforms are back in the limelight. On Thursday, Power Minister Awais Leghari announced that he...
New hope
12 Jul, 2025

New hope

EDUCATION shapes the destiny of a nation. Sadly, Pakistan’s public education sector is experiencing a national...
PIA privatisation
Updated 11 Jul, 2025

PIA privatisation

While it does give the privatisation authorities a much-needed head-start, it will not be sustainable unless preceded by policy and regulatory reforms.
Beyond expectations
11 Jul, 2025

Beyond expectations

THESE are tough times, but the country is lucky enough to still be considered home by a large expatriate workforce,...
Train in vain
11 Jul, 2025

Train in vain

TALK of ‘revival’ of the long-dead Karachi Circular Railway has turned into a running joke for denizens of this...